Ethicon Acquires Acclarent for $785,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1525-B O’Brien Drive Menlo Park, CA 94025
  • Company Description
    Initially, we are focused on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools – Balloon SinuplastyTM devices. Through the Balloon SinuplastyTM technology and our Relieva® product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The deal is valued at $785 million in cash.

Trending on Xconomy